SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-003456
Filing Date
2019-03-15
Accepted
2019-03-15 17:15:31
Documents
11
Period of Report
2019-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44150
2 ex1-1.htm EX-1.1 290046
3 ex5-1.htm EX-5.1 12012
4 ex99-1.htm EX-99.1 12107
5 ex99-2.htm EX-99.2 11849
6 ex99-1_001.jpg GRAPHIC 15518
7 ex99-2_001.jpg GRAPHIC 8743
8 ex99-3.htm EX-99.3 193092
9 ex99-4.htm EX-99.4 361281
10 ex99-3_001.jpg GRAPHIC 13539
11 ex99-3_002.jpg GRAPHIC 14459
  Complete submission text file 0001493152-19-003456.txt   998224
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 19685921
SIC: 2834 Pharmaceutical Preparations